Pennsylvania is on the brink of becoming the next state to fundamentally reshape its vaping marketplace. 

House Bill 1425, a nicotine vape product registry bill, has cleared the legislature and now sits on Governor Josh Shapiro’s desk. If signed, the law would significantly restrict which nicotine-containing vaping products can be sold in the state—not through an outright ban, but through the creation of a state-controlled product directory tied to federal PMTA status. 

This approach has become increasingly common across the U.S., and Pennsylvania’s version follows a familiar—but still controversial—pattern.

Sign the petition here. 

What Is HB 1425 Designed to Do? 

At its core, HB 1425 creates a state-managed directory of “approved” nicotine vaping products. Only products listed in that directory would be legal to sell in Pennsylvania once enforcement begins. 

The directory would be overseen by the state Attorney General and built entirely around the federal PMTA (Premarket Tobacco Application) process—a system that many independent manufacturers argue is still incomplete, inconsistent, and heavily skewed toward large tobacco-backed companies. 

 

Timeline: When Would This Take Effect? 

While the bill does not list firm calendar dates, the structure of the law establishes a clear rollout sequence: 

1. Governor signs the bill 
2. Directory published approximately six months later 
3. Retail enforcement begins about four months after publication 

That means businesses could have roughly 10 months total from signature to full enforcement—assuming the state adheres to the fastest allowable timeline. 

Once the directory is published, retailers would have a 120-day sell-through window to clear products not listed. 

 

What Manufacturers Would Be Required to Do 

HB 1425 places the primary burden on manufacturers, especially smaller or independent brands. 

To be listed in the directory, manufacturers must: 

• Certify under penalty of perjury that each product meets state requirements 
• Pay $2,000 per brand family and $200 per product style for initial submission 
• Pay reduced annual renewal fees in subsequent years 
• Secure a $50,000 surety bond 

Demonstrate that each product has: 

• FDA marketing authorization, or 
• A PMTA still under FDA review, or 
• A marketing denial order that has been stayed by a court or the FDA 

For companies with broad flavor lines or multiple device variations, these costs can escalate quickly. 

 

Importers and Distributors Face New Liability 

One of the less-discussed but most impactful sections of the bill targets importers of foreign-manufactured nicotine products. 

Under HB 1425: 

• Importers must appoint a registered agent within Pennsylvania 
• Importers assume joint liability with manufacturers for violations 
• Additional reporting and compliance obligations apply to imported products 

This effectively shifts legal risk downstream, making distributors responsible for enforcement failures—even if they did not manufacture the product. 

 

Retailers: Fines, License Risk, and Limited Flexibility 

Retailers would not be allowed to sell any nicotine product missing from the directory after the sell-through period ends. 

Penalties escalate quickly: 

• First violations begin at $500 
• Repeated violations increase in severity 

A third violation within 12 months can result in: 

• $1,000–$1,500 per product, and 
• Revocation of the retailer’s license 

Notably, the law does not penalize consumers for possession or purchase of non-listed products—only sellers and wholesalers. 

 

What Products Are Covered—and What Aren’t 

HB 1425 applies specifically to nicotine-containing products, including nicotine e-liquids. 

Based on current language: 

• Non-nicotine devices may be excluded 
• Hardware sold without nicotine does not appear to fall under the registry 

However, as seen in other states, enforcement interpretations can evolve, making clarity critical for retailers. 

 

A Growing National Trend 

If enacted, Pennsylvania would become the 14th state to adopt a PMTA registry law—and the fourth in 2025 alone, joining Arkansas, Mississippi, and Tennessee. 

More than 20 additional states have considered similar legislation, signaling that registry bills are rapidly becoming the preferred regulatory model at the state level. 

Critics argue these laws: 

• Reduce consumer choice 
• Disproportionately harm small and independent manufacturers 
• Create de facto market consolidation 
• Rely on an unfinished federal authorization process 

Supporters, meanwhile, frame them as enforcement tools—despite federal law reserving tobacco product authorization exclusively to the FDA. 

 

Why HB 1425 Matters Beyond Pennsylvania 

Pennsylvania is a large, diverse market. What happens here will influence: 

• Regional distribution strategies 
• Manufacturer product portfolios 
• Compliance planning nationwide 
• Future legislative efforts in neighboring states 

Whether the governor signs or vetoes HB 1425, the bill reflects a broader shift in how states are attempting to regulate vaping—by controlling access rather than behavior. 

 

Final Thoughts 

HB 1425 is not just another compliance bill—it represents a structural change to Pennsylvania’s nicotine vape market. If signed, it will reshape which products survive, who can afford to operate, and how businesses manage risk moving forward. 

For manufacturers, distributors, and retailers alike, now is the time to assess exposure, review PMTA status, and prepare for rapid regulatory change. 

The decision now rests with the governor—and the consequences will extend far beyond Harrisburg.